INIS
levels
100%
infusion
81%
fsh
54%
control
27%
vehicles
27%
menstrual cycle
27%
comparative evaluations
18%
length
18%
primates
18%
life span
18%
rhesus monkeys
18%
data
9%
in vivo
9%
humans
9%
peptides
9%
administration
9%
suppression
9%
secretion
9%
values
9%
reduction
9%
veins
9%
peaks
9%
monkeys
9%
estradiol
9%
progesterone
9%
gonadotropins
9%
bioassay
9%
Medicine and Dentistry
Infusion
81%
Inhibin
54%
Luteinizing Hormone
36%
Menstrual Cycle
27%
Serum
18%
Lifespan
18%
Inhibin A
18%
Activin A
18%
Peptide
9%
Bioassay
9%
Group Therapy
9%
Progesterone
9%
Estradiol
9%
Prematurity
9%
Menstruation
9%
Jugular Vein
9%
Gonadotropin Release
9%
Therapeutic Procedure
9%
Radioimmunoassay
9%
Biochemistry, Genetics and Molecular Biology
Activin
81%
Luteal Phase
45%
Menstrual Cycle
27%
Lifespan
18%
Primate
18%
Rhesus Monkey
18%
Length
18%
Peptide
9%
Progesterone
9%
Estradiol
9%
Gonadotropin Release
9%
Menstruation
9%
Contrast
9%
Reduction (Chemistry)
9%
Sample
9%
In Vivo Study
9%
Haplorhini
9%
Bioassay
9%
Rose
9%
Veterinary Science and Veterinary Medicine
Corpus Luteum
54%
Luteal Phase
45%
Progesterone
9%
Estradiol
9%